Bank of America
BXRX

Bank of America’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Bank of America’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 9126
2021
Q4 		– Hold
0
– – – 8957
2021
Q3 		– Hold
0
– – – 8609
2021
Q2 		– Hold
0
– – – 8347
2020
Q4 		– Hold
0
– – – 7510
2020
Q3 		– Sell
-1
Closed -$4.53K – 7328
2020
Q2 		$8K Sell
1
-2
-67% -$9.6K ﹤0.01% 6500
2020
Q1 		$11K Hold
3
– – ﹤0.01% 6346
2019
Q4 		$31K Buy
+3
New +$25.6K ﹤0.01% 6408

Other funds holding BXRX

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America's BXRX Position: Q1 2022 in Review

Bank of America held its Baudax Bio, Inc. Common Stock (BXRX) position steady in Q1 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #9126.

Bank of America first reported a position in BXRX in Q4 2019 and has held it in 3 quarters since. The position peaked at $31K in Q4 2019. 19 funds tracked by Wall St. Rank hold BXRX as of Q1 2022.

  • Bank of America held 0 shares of Baudax Bio, Inc. Common Stock worth $0 as of Q1 2022.
  • Bank of America left its Baudax Bio, Inc. Common Stock share count unchanged in Q1 2022.
  • Baudax Bio, Inc. Common Stock made up ﹤0.01% of Bank of America's portfolio in Q1 2022, its #9126 holding.
  • Bank of America first reported a position in Baudax Bio, Inc. Common Stock in Q4 2019 and has held it in 3 quarters since.
  • Bank of America's Baudax Bio, Inc. Common Stock position peaked at $31K in Q4 2019.
  • 19 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.